Ozmosi | CpG-STAT3 siRNA CAS3/SS3 Drug Profile
Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

CpG-STAT3 siRNA CAS3/SS3

Alternative Names: CpG-STAT3 siRNA CAS3/SS3, CpG-STAT3 siRNA, CpG-STAT3siRNA
Clinical Status: Inactive
Latest Update: 2024-05-15
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: TLR9 Inhibitor, STAT3 Inhibitor

Novel Mechanism: Yes

Modality: Nucleic Acid

Route of Administration: N/A

FDA Designation: *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: City of Hope Medical Center
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Phase 1: Diffuse Large B-Cell Lymphoma|B-Cell Marginal Zone Lymphoma|Chronic Lymphoid Leukemia|Lymphoma, Non-Hodgkin|Lymphocytic Chronic B-Cell Leukemia|Follicular Lymphoma|Mantle-Cell Lymphoma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated
NCI-2021-06965

P1

Withdrawn

Chronic Lymphoid Leukemia|Diffuse Large B-Cell Lymphoma|Mantle-Cell Lymphoma|Follicular Lymphoma|B-Cell Marginal Zone Lymphoma|Lymphocytic Chronic B-Cell Leukemia|Lymphoma, Non-Hodgkin

2024-01-04

2024-04-26

Primary Completion Date|Primary Endpoints|Start Date|Study Completion Date|Treatments

Recent News Events

Date

Type

Title

05/15/2024

PubMed

 Cost-Effectiveness Analysis of Digital Breast Tomosynthesis and Mammography in Breast Cancer Screening: A Markov Modeling Study.

05/01/2024

PubMed

 Bone marrow mesenchymal stem cell-derived exosomes shuttle microRNAs to endometrial stromal fibroblasts that promote tissue proliferation /regeneration/ and inhibit differentiation.

04/12/2024

PubMed

 Inequalities in women's health insurance coverage before and after the implementation of universal health insurance in Indonesia.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions